Population pharmacokinetics of doxorubicin: A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population pharmacokinetics of doxorubicin: A systematic review

Published:2022-04-12 Issue:1 Volume:19 Page:9-26
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Methaneethorn Janthima¹²^ORCID,Tengcharoen Kanokkan¹,Leelakanok Nattawut³,AlEjielat Rowan⁴

Affiliation:

1. Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences Naresuan University Phitsanulok Thailand

2. Center of Excellence for Environmental Health and Toxicology Naresuan University Phitsanulok Thailand

3. Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences Burapha University Sean Suk Thailand

4. Faculty of Pharmacy and Medical Sciences University of Petra Amman Jordan

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13776

Reference38 articles.

1. Clinical Pharmacokinetics of Doxorubicin

2. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

3. Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles

4. Bioanalysis of doxorubicin aglycone metabolites in human plasma samples–implications for doxorubicin drug monitoring

5. Doxorubicin Metabolism and Toxicity in Human Myocardium: Role of Cytoplasmic Deglycosidation and Carbonyl Reduction

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PBPK model of pegylated liposomal doxorubicin to simultaneously predict the concentration–time profile of encapsulated and free doxorubicin in tissues;Drug Delivery and Translational Research;2024-08-05

2. Population pharmacokinetics of TLD-1, a novel liposomal doxorubicin, in a phase I trial;Cancer Chemotherapy and Pharmacology;2024-06-15

3. Composite Hydrogel with Oleic Acid-Grafted Mesoporous Silica Nanoparticles for Enhanced Topical Delivery of Doxorubicin;Gels;2024-05-22

4. A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer;Frontiers in Oncology;2022-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3